Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-23T18:53:03.337Z Has data issue: false hasContentIssue false
  • English
  • Français

Infection and premature rupture of the membranes

Published online by Cambridge University Press:  10 October 2008

Kyung Seo ,
James A McGregor  and
Janice I French
Kyung Seo*
Affiliation:
Department of Obstetrics and Gynecology, University of Colorado Health Science Center, Denver, Colorado, USA
James A McGregor
Affiliation:
Department of Obstetrics and Gynecology, University of Colorado Health Science Center, Denver, Colorado, USA
Janice I French
Affiliation:
Department of Obstetrics and Gynecology, University of Colorado Health Science Center, Denver, Colorado, USA
*
Kyung Seo, Department of Obstetrics and Gynecology, University of Colorado Health Science Center, Denver, Colorado, USA.
Get access Rights & Permissions [Opens in a new window]

Premature rupture of the membranes (prom) and preterm birth

Preterm birth remains a paramount problem in health care worldwide. In the USA, approximately 6–10% of births occur preterm.1–3 Gestational age at birth is the most important determinant of an infant's morbidity and mortality. Preterm infants account for approximately 75% of neonatal deaths,3–5 as well as incalculable direct and indirect financial costs and morbidity.6–9

Type
Research Article
Information
Fetal and Maternal Medicine Review , Volume 2 , Issue 1 , January 1990 , pp. 1 - 19
Copyright
Copyright © Cambridge University Press 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Seigel, DG, Stanly, F. Statistics on perinatal morbidity and mortality. In: Quilligan, EJ, Kretchmer, N eds, Fetal and maternal medicine, New York: John Wiley, 1980; 3.Google Scholar
2Gunn, GC, Mishell, DR. Morton, DG. Premature rupture of the fetal membranes. Am J Obstet Gynecol 1970; 106: 469.CrossRefGoogle ScholarPubMed
3McCormick, MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985; 312: 82.CrossRefGoogle ScholarPubMed
4Naeye, RL. Causes of perinatal mortality in the US. Collaborative Perinatal Project. JAMA 1977; 238: 228.CrossRefGoogle ScholarPubMed
5Rush, RW, Keirse, MJNC. Howard, P et al. Contribution of preterm delivery to perinatal mortality. Br Med J 1976; 2: 965.CrossRefGoogle ScholarPubMed
6Konte, JM, Holbrook, RH Jnr, Larson, RK Jnr, Creasy, RK. Short-term neonatal morbidity associated with preterm birth and effect of a preterm birth prevention program on an expected incidence of morbidity. Am J Perinatol 1986; 3: 283.CrossRefGoogle Scholar
7Fitzhardinge, PM. Early growth and development in low birth weight infants following treatment in an intensive care nursery. Pediatrics 1975; 56: 162.CrossRefGoogle Scholar
8Allen, MC, Jones, MD. Medical complications of prematurity. Obstet Gynecol 1986; 67: 427.Google ScholarPubMed
9Hernandez, JA, Offtt, J, Butterfield, LJ. The cost of care of the less-than-1000-gram infant. Clin Perinatol 1986; 13: 461.CrossRefGoogle ScholarPubMed
10Kaltreider, DF, Kohl, S. Epidemiology of preterm delivery. Clin Obstet Gynecol 1980; 23: 17.CrossRefGoogle ScholarPubMed
11Naeye, RL, Peters, EC. Causes and consequences of premature rupture of fetal membranes. Lancet 1980; 1: 192.CrossRefGoogle ScholarPubMed
12Minkoff, H. Prematurity: infection as an etiologic factor. Obstet Gynecol 1983; 62: 137.Google ScholarPubMed
13Miller, JM, Pastorek, JG. The microbiology of premature rupture of the membranes. Clin Obstet Gynecol 1986; 29: 739.CrossRefGoogle ScholarPubMed
14Alger, LS, Pupkin, MJ. Etiology of preterm premature rupture of the membranes. Clin Obstet Gynecol 1986; 29: 758.CrossRefGoogle ScholarPubMed
15Lonkey, NM, Hayashi, RH. A proposed mechanism of premature rupture of membranes. Obstet Gynecol Surv 1988; 43: 22.CrossRefGoogle Scholar
16McGregor, JA. Preventing preterm birth caused by infection. Contemp Obstet Gynecol 1987; 29(4), 33.Google Scholar
17McGregor, JA. Prevention of preterm birth: New initiatives based on microbial-host interactions. Obstet Gynecol Surv 1988; 43: 1.CrossRefGoogle ScholarPubMed
18Romero, R, Major, M. Infection and preterm labour. Clin Obstet Gynecol 1988; 31: 553.CrossRefGoogle Scholar
19Romero, R, Quintero, R. Oyarzum E et al. Intraamniotic infection and the onset of labour in preterm premature rupture of the membranes. Am J Obstet Gynecol 1988; 159: 661.CrossRefGoogle Scholar
20Naeye, RL. Factors that predispose to premature rupture of the fetal membranes. Obstet Gynecol 1982; 60: 93.Google ScholarPubMed
21Eggers, TR, Doyle, LW. Pepperell, RJ. Premature rupture of the membranes. Med J Aust 1979; 1: 209.CrossRefGoogle ScholarPubMed
22Evaldson, G, Lagrelius, A, Winiarski, J. Premature rupture of the membranes. Acta Obstet Gynecol Scand 1980; 59: 385.CrossRefGoogle ScholarPubMed
23Wideman, GL, Baird, GH. Bolding, OT. Ascorbic acid deficiency and premature rupture of fetal membranes. Am J Obstet Gynecol 1964; 88: 592.CrossRefGoogle ScholarPubMed
24Artal, R, Burgeson, RE. Fernandez, FJ, Hobel, CJ. Fetal and maternal copper levels in patients at term with and without premature rupture of membranes. Obstet Gynecol 1979; 53: 5.Google ScholarPubMed
25Schlievert, P, Johnson, W. Galask, RP. Bacterial growth inhibition by amniotic fluid. V. Phosphate-to-zinc ratio as a predictor of bacterial growth-inhibitory activity. Am J Obstet Gynecol 1976; 125: 899.CrossRefGoogle ScholarPubMed
26Kiiholma, P, Grönroos, M, Erkkola, R et al. The role of calcium, copper, iron and zinc in preterm delivery and premature rupture of fetal membranes. Gynecol Obstet Invest 1984; 17: 194.CrossRefGoogle Scholar
27Naeye, RL, Ross, S. Coitus and chorioamnionitis: a prospective study. Early Hum Dev 1982; 6: 91.CrossRefGoogle ScholarPubMed
28Polansky, GH, Varner, MW. O'Gorman, T. Premature rupture of the membranes and barometric pressure changes. Lancet 1978; 1: 189.Google Scholar
29Naeye, RL, Blanc, WA. Relation of poverty and race to antenatal infection. N Engl J Med 1970; 283: 555.CrossRefGoogle ScholarPubMed
30Hardy, PH, Hardy, JB. Nell, EE et al. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 1984; 2: 333.CrossRefGoogle ScholarPubMed
31Naeye, RL. Seasonal variations in coitus and other risk factors, and the outcome of pregnancy. Early Hum Dev 1980; 4: 61.CrossRefGoogle ScholarPubMed
32Daikoku, NH, Kaltreider, F. Khouzami, VA et al. Premature rupture of the membrane and spontaneous preterm labour: maternal endometritis risks. Obstet Gynecol 1982; 59: 13.Google ScholarPubMed
33Dodds, WG, Iams, JD. Maternal C-reactive protein and preterm labour. J Reprod Med 1987; 32: 527.Google Scholar
34Handwerker, SM, Tejani, NA. Verma, UL et al. Correlation of maternal serum C-reactive protein with outcome of tocolysis. Obstet Gynecol 1984; 63: 220.Google ScholarPubMed
35Hawrylyshyn, P, Bernstein, P. Milligan, JE et al. Premature rupture of the membranes: the role of C-reactive protein in the prediction of chorioamnionitis. Am J Obstet Gynecol 1983; 147: 240.CrossRefGoogle ScholarPubMed
36Evans, MI, Hajj, SN. Devoe, LD et al. C- reactive protein as a predictor of infection morbidity with premature rupture of the membranes. Am J Obstet Gynecol 1980; 138: 648.CrossRefGoogle Scholar
37Buetow, KC, Klein, SW. Lane, RB. Septicemia in premature infants Am J Dis Child 1965; 110: 29.CrossRefGoogle ScholarPubMed
38Daikoku, NH, Kaltreider, F. Johnson, TRB et al. Premature rupture of the membrane and preterm labour: neonatal infection and perinatal mortality risks. Obstet Gynecol 1981; 58: 417.Google ScholarPubMed
39Cederqvist, LL, Zervoudakis, IA. Ewool, LC, Litwin, SD. The relationship between prematurely ruptured membranes and fetal immunoglobulin production. Am J Obstet Gynecol 1979; 134: 784.CrossRefGoogle ScholarPubMed
40Guzick, DS, Winn, K. The association of chorioamnionitis and preterm delivery. Obstet Gynecol 1985; 65: 11.Google ScholarPubMed
41Chellam, VG, Rushton, DI. Chorioamnionitis and funiculitis in the placenta of 200 births weighing less than 2.5 kg. Br J Obstet Gynaecol 1985; 92: 808.CrossRefGoogle Scholar
42Pankuch, GA, Appelbaum, PC. Lorenz, RP et al. Placental microbiology and histology and the pathogenesis of chorioamnionitis. Obstet Gynecol 1984; 64: 802.Google ScholarPubMed
43Hillier, SH, Martius, J. Krohn, M et al. A casecontrol study of chorioamniotic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988; 319: 972.CrossRefGoogle Scholar
44Miller, JM, Hill, GB. Welt, SI, Pupkin, MJ. Bacterial colonization of amniotic fluid in the presence of ruptured membranes. Am J Obstet Gynecol 1980; 137: 451.CrossRefGoogle ScholarPubMed
45Knox, IC. The role of infection in premature rupture of the membrane. Am J Obstet Gynecol 1950; 59: 190.CrossRefGoogle Scholar
46Creatsas, G, Pavlatos, M. Lolis, D et al. Bacterial contamination of the cervix and premature rupture of membranes. Am J Obstet Gynecol 1981; 139: 522.CrossRefGoogle ScholarPubMed
47Minkoff, HL, Grunebaum, AN. Schwarz, RH et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984; 150: 965.CrossRefGoogle ScholarPubMed
48McGregor, JA, French, JI. Richter, R et al. Cervico-vaginal microbial-host interaction and maternal and perinatal outcomes: refining the hypothesis. Abstract #63, Society for Gynecologic Investigation Scientific Program and Abstracts, Baltimore, Maryland, March 17–20, 1988: 91.Google Scholar
49Amstey, MS, Steadman, KY. Asymptomatic gonorrhea and pregnancy. J Am Vener Dis Assoc 1976; 3: 14.Google ScholarPubMed
50Regan, JA, Chao, S. James, LS. Premature rupture of the membranes, preterm delivery, and group B streptococcal colonization of mothers. Am J Obstet Gynecol 1981; 141: 184.CrossRefGoogle Scholar
51Martin, DH, Koutsky, L. Eschenbach, DA et al. Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA 1982; 247: 1585.CrossRefGoogle ScholarPubMed
52Harrison, HR, Alexander, ER. Weinstein, L et al. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes. JAMA 1983; 250: 1721.CrossRefGoogle ScholarPubMed
53Gravett, MG, Nelson, HP. DeRouen, T et al. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986; 256: 1899.CrossRefGoogle ScholarPubMed
54Braun, P, Lee, Y-H, Klein, JO et al. Birthweight and genital mycoplasmas in pregnancy. N Engl J Med 1971; 284: 167.CrossRefGoogle ScholarPubMed
55Kundsin, RB, Driscoll, SG. Monson, RR et al. Association of ureaplasma urealyticum in the placenta with perinatal morbidity and mortality. N Engl J Med 1984; 310: 941.CrossRefGoogle ScholarPubMed
56Gravett, MG, Hummel, D. Eschenbach, DA et al. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986; 67: 229.CrossRefGoogle ScholarPubMed
57Miller, JM, Pupkin, MJ. Hill, GB. Bacterial colonization of amniotic fluid from intact fetal membranes. Am J Obstet Gynecol 1980; 136: 796.CrossRefGoogle ScholarPubMed
58Bobitt, JR, Ledger, WJ. Unrecognized amnionitis and prematurity. A preliminary report. J Reprod Med 1977; 19: 8.Google ScholarPubMed
59Hameed, C, Tejani, N. Verma, UL et al. Silent chorioamnionitis as a cause of preterm labor refractory to tocolytic therapy. Obstet Gynecol 1984; 149: 726.Google ScholarPubMed
60Plaut, AG. Microbial IgA proteases. N Engl J Med 1978; 298: 1459.Google ScholarPubMed
61 Kapatais-Zoumbos, K, Chandler, DKF. Bariie, MF. Survey of immunoglobulin A protease activity among selected species of Ureaplasma and Mycoplasma: specificity for host immunoglobulin A. Infect Immun 1985; 47: 404.CrossRefGoogle ScholarPubMed
62McGregor, JA, Lawellin, D. Schroeter, U et al. IGG protease activity in microorganisms associated with upper genital tract infection determined by ELISA. Abstracts #157P, Society for Gynecologic Investigation Scientific Program and Abstracts, Toronto, Ontario, Canada, March 19–22, 1986: 111.Google Scholar
63McGregor, JA, Lawellin, D. Franco-Buff, A et al. Mucinase (neuraminidase) production in microorganisms associated with upper genital tract infection. Abstracts #159P, Society for Gynecologic Investigation Scientific Program and Abstracts, Toronto, Ontario, Canada, March 19–22, 1986: 112.Google Scholar
64Galask, RP, Snyder, IS. Bacterial inhibition by amniotic fluid. Am J Obstet Gynecol 1968; 102: 949.CrossRefGoogle ScholarPubMed
65Bergman, N, Bercovici, B. Sacks, T. Antibacterial activity of human amniotic fluid. Am J Obstet Gynecol 1972; 114: 520.CrossRefGoogle ScholarPubMed
66Larsen, B, Snyder, IS. Galask, RP. Bacterial growth inhibition by amniotic fluid. I. In vitro evidence for bacterial growth inhibitory activity. Am J Obstet Gynecol 1974, 119: 492.CrossRefGoogle Scholar
67Thadepalli, H, Bach, T. Davidson, EC. Antimicrobial effect of amniotic fluid. Obstet Gynecol 1978; 52: 198.Google ScholarPubMed
68Schlievert, P, Larsen, B. Johnson, W et al. Bacterial growth inhibition by amniotic fluid. III. Demonstration of the variability of bacterial growth inhibition by amniotic fluid with a new plate-count technique. Am' J Obstet Gynecol 1975; 122: 809.CrossRefGoogle ScholarPubMed
69Cherry, SH, Filler, M. Harvey, H. Lysozyme content of amniotic fluid. Am J Obstet Gynecol 1973; 116: 639.CrossRefGoogle ScholarPubMed
70Gusdon, JP. A bactericidin present for Bacillus subtilis in pregnancy. J Immunol 1962; 88: 494.CrossRefGoogle Scholar
71Usategui-Gomez, J, Morgan, DF. Toolan, HW. A comparative study of amniotic fluid, maternal serum, and cord sera by disc electrophoresis. Proc Soc Exp Biol Med 1966; 123: 547.CrossRefGoogle Scholar
72Larsen, B, Snyder, IS. Galask, RP. Transferrin concentration in human amniotic fluid. Am J Obstet Gynecol 1973; 117: 952.CrossRefGoogle ScholarPubMed
73Thadepalli, H, Gangopadhyay, PK. Maidman, JE. Amniotic fluid analysis for antimicrobial factors. Int J Gynaecol Obstet 1982; 20: 65.CrossRefGoogle ScholarPubMed
74Larsen, B, Galask, RP, Snyder, IS. Muramidase and peroxidase activity of human amniotic fluid. Obstet Gynecol 1974; 44: 219.Google ScholarPubMed
75Schlievert, P, Johnson, W. Galask, RP. Amniotic fluid antibacterial mechanism: newer concepts. Semin Perinatol 1977; 1: 59.Google ScholarPubMed
76Gonik, B, Bottoms, SF. Cotton, DB. Amniotic fluid volume as a risk factor in preterm premature rupture of the membranes. Obstet Gynecol 1985; 65: 456.Google ScholarPubMed
77Blanco, JD, Gibbs, RS, Krebs, LK, Castaneda, YS. The association between the absence of amniotic fluid inhibitory activity and intraamniotic infection. Am J Obstet Gynecol 1982; 143: 749.CrossRefGoogle Scholar
78Nazir, MA, Pankach, GA. Botti, JJ et al. Antibacterial activity of amniotic fluid in the early third trimester. Am J Perinatol 1987; 4: 59.CrossRefGoogle ScholarPubMed
79MacDonald, PC, Porter, JC. Schwarz, BE et al. Initiation of parturition in human female. Sem Perinatol 1978; 2: 273.Google ScholarPubMed
80Bennet, PR, Elder, MG, Myatt, L. The effect of lipoxygenase metabolites of arachidonic acid on human myometrial contractility. Prostaglandins 1987; 33: 837.CrossRefGoogle Scholar
81Bejar, R, Curbelo, V, Davis, C, Gluck, L. Premature labor: bacterial sources of phospholipase. Obstet Gynecol 1981; 57: 479.Google ScholarPubMed
82McGregor, JA, Lawellin, D, Franco-Buff, A et al. Phospholipase A2 activity of genital tract microflora detected with two substrates. Abstracts #153, Society for Gynecologic Investigation Scientific Program and Abstracts, Phoenix, Arizona, 03 20–23, 1985.Google Scholar
83McGregor, JA, Lawellin, D, Franco-Buff, A et al. Phospholipase C production by microorganisms associated with female upper genital tract infections. Abstracts #362P, Society for Gynecologic Investigation Scientific Progam and Abstracts, Phoenix, Arizona, 03 20–23, 1985: 208.Google Scholar
84Lamon, RF, Rose, M, Elder, MG. Effects of bacterial products on prostaglandin E production by amnion cells. Lancet 1985; 2: 1131.Google Scholar
85Bennet, PR, Rose, MP, Myatt, L. Preterm labor: stimulation of arachidonic acid metabolism in human amnion by bacterial products. Am J Obstet Gynecol 1987; 156: 649.CrossRefGoogle Scholar
86McGregor, JA. Microorganisms and arachidonic acid metabolites in preterm birth. Semin Reprod Endocrinol 1985; 3: 273.CrossRefGoogle Scholar
87McGregor, JA, Todd, J, Lawellin, D et al. The formation of arachidonic acid metabolites by cervical/vaginal microorganisms. Abstracts #28P, Society for Gynecologic Investigation Scientific Program and Abstracts, Phoenix, Arizona, 03 20–23, 1985: 17.Google Scholar
88Lawellin, D, Kishiyama, J, Carson, J et al. Formation of arachidonic acid metabolites by cervical/vaginal microorganisms. Society for Gynecologic Investigation Scientific Program and Abstracts, Phoenix, Arizona, 03 20–23, 1985: 20.Google Scholar
89Ban, C, Billah, MM, Truong, CT, Johnston, JM, Metabolism of platelet activating factor in human fetal membranes and decidua vera. Arch Biochem Biophys 1986; 246: 9.CrossRefGoogle ScholarPubMed
90 O'Flaherty, JT, Wykle, R. Biology and biochemistry of platelet activating factor. Clin Rev Allergy 1983; 1: 353.CrossRefGoogle ScholarPubMed
91Nishihira, J, Ishibashi, T, Imai, Y, Muramatsu, T. Mass spectrometric evidence for the presence of platelet-activating factor in human amniotic fluid during labor. Lipids 1984; 19: 907.CrossRefGoogle ScholarPubMed
92Huang, K, Wallner, BP, Mattaliano, RJ et al. Two human 35 KD inhibitors of phospholipase A2 are related to substrates of pp60 v-src and of the epidermal growth factor/kinase. Cell 1986; 46: 191.CrossRefGoogle Scholar
93Kurland, JI, Bockman, R. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med 1978; 147: 952.CrossRefGoogle ScholarPubMed
94Romero, R, Hobbins, JC. Mitchell, MD. Endotoxin stimulates prostaglandin E2 production by human amnion. Obstet Gynecol 1988; 71: 227.Google ScholarPubMed
95Romero, R, Kadar, N, Hobbins, JC, Duff, GW. Infection and labor: the detection of endotoxin in amniotic fluid. Am J Obstet Gynecol 1987; 157: 815.CrossRefGoogle ScholarPubMed
96Romero, R, Roslansky, P, Oyarzum, E et al. Labor and infection II. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor. Am J Obstet Gynecol 1988; 158: 1044.CrossRefGoogle Scholar
97Nathan, CF. Secretory products of macrophage. J Clin Invest 1987; 79: 319.CrossRefGoogle Scholar
98Dinarello, CA. Interleukin-1. Rev Infect Dis 1984; 6: 51.CrossRefGoogle ScholarPubMed
99Mitzel, SB, Dayer, JM, Krane, SM et al. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte activating factor (interleukin 1). Proc Natl Acad Sci USA 1981; 78: 2474.CrossRefGoogle Scholar
100Jyonouchi, H, Voss, RM, Good, KA. IL 1-like activities present in murine amniotic fluid. A significantly larger amount of IL 1 beta-like activity is present in the amniotic fluid of autoimmune NZB mice. J Immunol 1987; 138: 3300.CrossRefGoogle ScholarPubMed
101Ito, A, Hiro, D, Ojima, Y et al. Spontaneous production of interleukin-1-like factors from pregnant rabbit uterine cervix. Am J Obstet Gynecol 1988; 159: 261.CrossRefGoogle ScholarPubMed
102Romero, R, Brody, DT, Oyarzum, E et al. Infection and labor III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989; 160: 1117.CrossRefGoogle Scholar
103Beutler, B, Creami, A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 316: 379.Google ScholarPubMed
104Jaattella, M, Kuusela, P. Saksela, E. Demonstration of tumor necrosis factor in human amniotic fluid and supernatants of placental and decidual tissue. Lab Invest 1988; 58: 48.Google Scholar
105Romero, R, Manogue, K, Wu, YK et al. Tumor necrosis factor. A signal for the initiation of labor in chorioamnionitis. Abstract presented at the 8th Annual Meeting of the Society of Perinatal Obstetricians.Las Vegas,1988.Google Scholar
106Kent, J, Witkin, S, Druzin, M. Elevated levels of IL2 receptor as a serologic marker for preterm birth in women with preterm labor. Society for Gynecologic Investigation Scientific Program and Abstracts 1988: 100.Google Scholar
107Bartocci, A, Pollard, JW, Stanley, ER. Regulation of colony-stimulating factor 1 during pregnancy. J Exp Med 1986; 164: 956.CrossRefGoogle ScholarPubMed
108Ringler, GE, Coutifaris, C, Strauss, JF et al. Accumulation of colony-stimulating factor 1 in amniotic fluid during pregnancy. Am J Obstet Gynecol 1989; 160: 655.CrossRefGoogle Scholar
109Artal, R, Burgeson, RE, Hobel, CJ et al. An in vitro model for the study of enzymatically mediated biomechanical changes in the chorioamniotic mebrane. Am J Obstet Gynecol 1979; 133: 656.CrossRefGoogle Scholar
110McGregor, JA, Schoonmaker, JN, French, JI et al. Impairment of amniochorion strength, elasticity and work to rupture by neutrophils, lymphocytes, and leukocyte elastase. Abstract #25, Society for Gynecologic Investigation Scientific Program and Abstracts, Baltimore, Maryland, 03 17–20, 1988: 72.Google Scholar
111McGregor, JA. Unpublished data.Google Scholar
112McGregor, JA, Lawellin, D, Franco-Buff, A.. Protease production by microorganisms associated with reproductive tract infection. Am J Obstet Gynecol 1986; 154: 109.CrossRefGoogle ScholarPubMed
113McGregor, JA, French, JI. Lawellin, D et al. In vitro study of bacterial protease-induced reduction of chorioamniotic membrane strength and elasticity. Obstet Gynecol 1987; 69: 167.Google Scholar
114Skinner, SJM, Campos, GA. Liggins, GC. Collagen content of human amniotic membranes: effect of gestation length and premature rupture. Obstet Gynecol 1981; 57: 487.Google ScholarPubMed
115Kanayama, N, Terao, T. Kawashima, Y et al. Collagen types in normal and prematurely ruptured amniotic membranes. Am J Obstet Gynecol 1985; 153: 899.CrossRefGoogle ScholarPubMed
116Mainardi, CL, Hasty, DL. Seyer, JM et al. Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem 1980; 255: 12006.CrossRefGoogle ScholarPubMed
117Warwas, M, Dobryszycka, W. Cathepsin B1 from human fetal membranes. Biochem Biophys Acta 1976; 429: 573.Google ScholarPubMed
118Burgos, H, Hsi, BL, Yeh, CJG, Faulk, WP. Plasminogen binding by human amniochorion: a possible factor in premature rupture of the membranes. Am J Obstet Gynecol 1982; 143: 958.CrossRefGoogle Scholar
119Jenkins, DM, France, VM, Hsi, B, Faulk, WP. Degenerative changes and detection of plasminogen in fetal membranes that rupture prematurely. Br J Obstet Gynaecol 1983; 90: 841.CrossRefGoogle ScholarPubMed
120Kanayama, N, Kamijo, H. Tera, T et al. The relationship between trypsin activity in amniotic fluid and premature rupture of membranes. Am J Obstet Gynecol 1986; 155: 1043.CrossRefGoogle ScholarPubMed
121Milwidsky, A, Hurwitz, A. Eckstein, L et al. Proteolytic enzymes in human fetal membranes and amniotic fluid. A comparison of normal and premature ruptured membranes. Enzyme 1985; 33: 188.CrossRefGoogle ScholarPubMed
122Sutcliffe, RG, Brock, DJN. Immunological studies on the nature and origin of the major proteins in amniotic fluid. J Obstet Gynaecol Br Commonw 1973; 80: 721.CrossRefGoogle ScholarPubMed
123Gibaud, S, Bonnet, M, Thoulon, JM, Dumont, M. Alpha 1-antitrypsin in amniotic fluid. Obstet Gynecol 1975; 45: 34.Google Scholar
124Bhat, AR, Issac, V, Pattabiraman, TN. Protease inhibitors in serum and amniotic fluid during pregnancy. Br J Obstet Gynaecol 1979; 86: 222.CrossRefGoogle ScholarPubMed
125Burnett, D, Bradwell, AR. The origin of plasma proteins in human amniotic fluid. The significance of alpha 1-antichymotrypsin complexes. Biol Neonate 1980; 37: 302.CrossRefGoogle ScholarPubMed
126Bhat, AR, Pattabiraman, TN. Urinary proteinase inhibitor in premature infants and its comparison with amniotic-fluid acid-stable proteinase inhibitor. Biochem Med 1982; 27: 168.CrossRefGoogle ScholarPubMed
127Stricklin, GP, Gast, MJ. Welgus, HG. Amniotic fluid collagenase inhibitor: correlation with gestational age and fetal lung maturity. Am J Obstet Gynecol 1986; 154: 134.CrossRefGoogle ScholarPubMed
128Sbarra, AJ, Selvaraj, RJ, Cetrulo, CL et al. Infection and phagocytosis as possible mechanism of rupture in premature rupture of the membrane. Am J Obstet Gynecol 1985; 153: 38.CrossRefGoogle Scholar
129Sbarra, AJ, Thomas, GB. Cetrulo, CL. Effect of bacterial growth on the bursting pressure of fetal membrane in vitro. Obstet Gynecol 1987; 70: 107.Google ScholarPubMed
130Elder, HA, Santamarina, BAG, Smith, S et al. The effect of tetracycline on the clinical course and the outcome of pregnancy. Am J Obstet Gynecol 1971; 111: 441.CrossRefGoogle ScholarPubMed
131McGregor, JA, French, JI, Reller, B et al. Adjunctive erythromycin treatment for idiopathic preterm labor: result of a randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol 1986; 154: 98.CrossRefGoogle ScholarPubMed
132Thomsen, AC, Morup, L, Hansen, KB. Antibiotic elimination of group-B streptococci in urine in prevention of preterm labor. Lancet 1987; 1: 591.CrossRefGoogle Scholar
133McGregor, JA, French, JI, Richter, R et al. Prospective, double-blinded, randomized, placebo-controlled trial of short-course erythromycin base in women at high risk for preterm birth. Abstract #62, Society for Gynecologic Investigation Scientific Program and Abstracts, Baltimore, Maryland, 03 17–20, 1988: 90.Google Scholar
134Blackmon, LR, Alger, LS, Crenshaw, C. Fetal and neonatal outcomes associated with premature rupture of the membranes. Clin Obstet Gynecol 1986; 29: 779.CrossRefGoogle ScholarPubMed
135Garite, TJ, Freeman, RK. Chorioamnionitis in the preterm gestation. Obstet Gynecol 1982; 54: 539.Google Scholar
136Varner, MW, Galask, RP. Conservative management of premature rupture of the membranes. Am J Obstet Gynecol 1981; 140: 39.CrossRefGoogle Scholar
137Schreiber, J, Benedetti, T. Conservative management of preterm premature rupture of the fetal membranes in a low socioeconomic population. Am J Obstet Gynecol 1980; 136: 92.CrossRefGoogle Scholar
138Yoder, PR, Gibbs, RS, Blanco, JD et al. A prospective, controlled study of maternal and perinatal outcome after intraamniotic infection at term. Am J Obstet Gynecol 1983; 145: 695.CrossRefGoogle ScholarPubMed
139Wilson, JC, Levy, DC, Wilds, PL. Premature rupture of membranes prior to term: consequences of non-intervention. Obstet Gynecol 1982; 60: 601.Google Scholar
140Berkowitz, RL, Hoder, L, Freeman, RM et al. Results of a management protocol for premature rupture of the membranes. Obstet Gynecol 1982; 60: 271.Google ScholarPubMed
141 StGeme, JW. Perinatal and neonatal infections. West J Med 1975; 122: 359.Google ScholarPubMed
142 StGeme, JW, Murray, DL, Carter, J et al. Perinatal bacterial infection after prolonged rupture of amniotic membranes: an analysis of risk and management. J Pediatr 1984; 104: 608.CrossRefGoogle Scholar
143Graham, RL, Gilstrap, LC, Hauth, JC et al. Conservative management of premature rupture of fetal membranes. Obstet Gynecol 1982; 59: 607.Google ScholarPubMed
144Bada, HS, Alojipan, LC, Andrews, BF. Premature rupture of membranes and its effect on the newborn. Pediatr Clin North Am 1977; 24: 491.CrossRefGoogle ScholarPubMed
145Brame, RG, MacKenna, J. Vaginal pool phospholipids in management of premature rupture of membranes. Am J Obstet Gynecol 1983; 145: 992.CrossRefGoogle ScholarPubMed
146Garite, TJ, Freeman, RK, Linzey, EM et al. Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation. Am J Obstet Gynecol 1981; 141: 508.CrossRefGoogle ScholarPubMed
147Thibeault, DW, Emmanouilides, GC. Prolonged rupture of fetal membranes and decreased frequency of respiratory distress syndrome and patent ductus arteriosus in preterm infants. Am J Obstet Gynecol 1977; 129: 43.CrossRefGoogle ScholarPubMed
148Fayez, JA, Hasan, AA, Jonas, HS et al. Management of premature rupture of the membranes. Obstet Gynecol 1978; 52: 17.Google ScholarPubMed
149Buemann, B, Lange, P. Premature rupture of the membranes at fetal weights of 1000 to 2500 g. Acta Obstet Gynecol Scand 1962; 41: 346.CrossRefGoogle Scholar
150Johnson, JWC, Daikoku, NH, Niebyl, JR et al. Premature rupture of the membranes and prolonged latency. Obstet Gynecol 1981; 57: 547.Google ScholarPubMed
151Schutte, MF, Treffers, PE, Kloosterman, GJ, Soepatoni, S. Management of premature rupture of membranes: the risk of vaginal examination to the infant. Am J Obstet Gynecol 1978; 61: 171.Google Scholar
152Gibbs, RS. Diagnosis of intra-amniotic infection. Semin Perinatol 1977; 1: 71.Google ScholarPubMed
153Romen, Y, Artal, R. C-reactive protein as a predictor for chorioamnionitis in cases of premature rupture of the membranes. Am J Obstet Gynecol 1984; 150: 546.CrossRefGoogle Scholar
154Ismail, MA, Zinaman, MJ, Lowensohn, RI, Moaward, AH. The significance of C-reactive protein levels in women with premature rupture of membranes. Am J Obstet Gynecol 1985; 151: 541.CrossRefGoogle ScholarPubMed
155Farb, HF, Arnesser, M, Geistler, P, Knox, GE. C-reactive protein with premature rupture of membranes and premature labor. Obstet Gynecol 1983; 62: 49.Google ScholarPubMed
156Levy, DL, Arguembourg, PC. Maternal and blood complement activity: relationship to premature rupture of the membranes. Am J Obstet Gynecol 1981; 139: 38.CrossRefGoogle ScholarPubMed
157Vintzileos, AM, Campbell, WA, Nochimson, DJ et al. Fetal biophysical profile versus amniocentesis in predicting infection in preterm premature rupture of the membranes. Obstet Gynecol 1986; 68: 488.Google ScholarPubMed
158Goldstein, I, Romero, R, Merrill, S et al. Fetal body and breathing movements as predictors of intraamniotic infection in preterm premature rupture of membranes. Am J Obstet Gynecol 1988; 159: 363.CrossRefGoogle ScholarPubMed
159Larsen, J, Weis, K, Leniham, J et al. Significance of neutrophils and bacteria in the amniotic fluid of patients in labor. Obstet Gynecol 1976; 47: 143.Google ScholarPubMed
160Gibbs, RS, Blanco, JD, StClair, PJ, Castenada, YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis 1982; 145: 1.CrossRefGoogle Scholar
161Listwa, HM, Dobek, AS, Carpenter, J, Gibbs, RS. Predictability of intrauterine infection by analysis of amniotic fluid. Obstet Gynecol 1976; 48: 31.Google ScholarPubMed
162Romero, R, Emamian, M, Quintero, R et al. The value and limitations of the gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol 1988; 159: 114.CrossRefGoogle ScholarPubMed
163Gravett, MG, Eschenbach, DA, Spiegel-Brown, CA, Holmes, KK. Rapid diagnosis of amniotic fluid infection by gas liquid chromatography. N Engl J Med 1982; 306: 725.CrossRefGoogle ScholarPubMed
164Garite, TJ, Freeman, RK, Linzey, EH, Braley, P. The use of amniocentesis in patients with premature rupture of membranes. Obstet Gynecol 1979; 54: 226.Google ScholarPubMed
165Zlatnick, FJ, Cruikshank, DP, Petzold, CR, Galask, RP. Amniocentesis in the identification of inapparent infection in preterm patients with premature rupture of the membranes. J Reprod Med 1984; 29; 656.Google Scholar
166Cotton, DB, Hill, LM, Strassner, HT et al. Use of amniocentesis in preterm gestation with ruptured membranes. Obstet Gynecol 1984; 63: 38.Google ScholarPubMed
167Broekhuizen, FF, Gilman, M, Hamilton, PR. Amniocentesis for gram stain and culture in preterm premature rupture of the membranes Obstet Gynecol 1985; 66: 316.Google ScholarPubMed
168Vintzileos, AM, Campbell, WA, Nochimson, DJ et al. Qualitative amniotic volume versus amniocentesis in predicting infection in preterm rupture of the membranes. Obstet Gynecol 1986; 67: 579.Google ScholarPubMed
169Feinstein, ST, Vintzileos, AM, Lodeiro, JG et al. Amniocentesis with premature rupture of the membranes. Am J Obstet Gynecol 1986; 68: 147.Google Scholar
170Blanco, JD, Gibbs, RS, Krebs, LK. A controlled study of amniotic fluid immunoglobulin levels in intraamniotic infection. Obstet Gynecol 1983; 61: 450.Google ScholarPubMed
171Ismail, MA, Yang, S, Abusarif, AN, Moawad, AH. Immunoglobulins in prolonged ruptured membranes. Am J Obstet Gynecol 1985; 153: 390.CrossRefGoogle ScholarPubMed
172Benirschke, K, Clifford, SH. Intrauterine bacterial infection of the newborn infant – frozen sections of the cord as an aid to early diagnosis. J Pediatr 1959; 54: 11.CrossRefGoogle Scholar
173Overbach, AM, Daniel, SJ, Cassady, G. The value of umbilical cord histology in the management of potential perinatal infection. J Pediatr 1970; 76: 22.CrossRefGoogle ScholarPubMed
174Maudsley, RF, Brix, GA. Hinton, NA et al. Placental inflammation and infection: a prospective bacteriologic and histologic study. Am J Obstet Gynecol 1966; 95: 648.CrossRefGoogle ScholarPubMed
175Dong, Y, St. Clair, PJ, Ramzy, I et al. A microbiologic and clinical study of placental inflammation at term. Obstet Gynecol 1987; 70: 175.Google ScholarPubMed
176Driscoll, SG. Significance of acute chorioamnionitis. Clin Obstet Gynecol 1979; 22: 339.CrossRefGoogle ScholarPubMed
177Kappy, KA, Certulo, CL, Knuppel, RA et al. Premature rupture of the membranes: a conservative approach. Am J Obstet Gynecol 1979; 134: 655.CrossRefGoogle Scholar
178Capeless, EL, Mead, PB. Management of premature rupture of membranes: lack of consensus. Am J Obstet Gynecol 1987; 157: 11.CrossRefGoogle Scholar
179Lebherz, TB, Hellman, LP, Madding, R et al. Double-blind study of premature rupture of the membranes. Am J Obstet Gynecol 1963; 87: 218.CrossRefGoogle ScholarPubMed
180Amon, E, Lewis, SV, Sibbai, BM et al. Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol 1988; 159: 539.CrossRefGoogle ScholarPubMed
181McGregor, JA, French, JI. Double-blind randomized, placebo controlled, prospective evaluation of the efficacy of short course erythromycin in prolonging gestation among women with preterm rupture of membranes. Abstract, Society of Perinatal Obstetricians, 1988.Google Scholar
182Morales, WJ, Angel, JL, O'Brien, WF et al. Use of ampicillin and corticosteroids in premature rupture of membranes: A randomized study. Obstet Gynecol 1989; 73: 721.Google ScholarPubMed
183Ogita, S, Mizuno, M, Takeda, Y et al. Clinical effectiveness of a new cervical indwelling catheter in the management of premature rupture of the membranes: a Japanese collaborative study. Am J Obstet Gynecol 1988; 159: 336.CrossRefGoogle Scholar
184Iams, JD, Talbert, ML, Barrows, H et al. A prospective randomized comparison of observation versus use of steroids and timed delivery. Am J Obstet Gynecol 1985; 151: 32.CrossRefGoogle ScholarPubMed
185Kuhn, RJP, Speirs, AL, Pepperell, RJ et al. Betamethasone, albuterol and threatened premature delivery: benefits and risks. Obstet Gynecol 1982; 60: 403.Google ScholarPubMed
186Morales, WJ, Diebel, ND, Lazar, AJ et al. The effect of antenatal dexamethasone administration on prevention of respiratory distress syndrome in preterm gestations with premature rupture of the membranes. Am J Obstet Gynecol 1986; 154: 591.CrossRefGoogle Scholar
187Nelson, LH, Meis, PJ, Hatjis, CG et al. Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstet Gynecol 1985; 66: 55.Google ScholarPubMed
188Schmidt, PL, Sims, ME, Strassner, HT et al. Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. Am J Obstet Gynecol 1984; 148: 178.CrossRefGoogle ScholarPubMed
189Simpson, GF, Harbert, GH Jnr. Use of betamethasone in management of preterm gestation with premature rupture of membranes. Obstet Gynecol 1985; 66: 168.Google ScholarPubMed
190Taeusch, HW, Frigoletto, F, Kitzmiller, J et al. Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics 1979; 63: 64.CrossRefGoogle ScholarPubMed
191Young, BK, Klein, SA, Katz, M et al. Intravenous dexamethasone for prevention of neonatal respiratory distress: a prospective controlled study. Am J Obstet Gynecol 1980; 138: 203.CrossRefGoogle ScholarPubMed
192Bourgeois, FJ, Harbert, GM, Anderson, WA et al. Early versus late tocolytic treatment for preterm premature membrane rupture. Am J Obstet Gynecol 1988; 159: 742.CrossRefGoogle ScholarPubMed
193Christensen, KK, Ingemarsson, I, Leideman, T et al. Effects of ritodrine on labor after premature rupture of the membranes. Obstet Gynecol 1987; 157: 388.Google Scholar
194Garite, TJ, Keegan, KA, Freeman, RK et al. A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of membranes at 25 to 30 weeks of gestation. Am J Obstet Gynecol 1987; 157: 388.CrossRefGoogle ScholarPubMed
195Weiner, CP, Renk, K, Klugman, M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol 1988; 159: 216.CrossRefGoogle ScholarPubMed
196Curet, LB, Rao, AV, Zachman, RD et al. Association between ruptured membranes, tocolytic therapies, and respiratory distress syndrome. Am J Obstet Gynecol 1984; 148: 263.CrossRefGoogle Scholar
197McGregor, JA, Schoonmaker, J, Lunt, B et al. Antimicrobial inhibition of bacteria-mediated fetal membrane alterations. Abstract, Infectious Disease Society for Obstetrics – Gynecology, The Crestwood Snowmass Village, Colorado, 08 4–6, 1988.Google Scholar